Ventyx Biosciences Inc (VTYX)
4.80
-0.01
(-0.21%)
USD |
NASDAQ |
May 31, 16:00
4.79
-0.01
(-0.21%)
After-Hours: 20:00
Ventyx Biosciences Market Cap: 338.40M for May 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 338.40M |
| May 30, 2024 | 339.10M |
| May 29, 2024 | 347.56M |
| May 28, 2024 | 361.66M |
| May 24, 2024 | 308.08M |
| May 23, 2024 | 313.72M |
| May 22, 2024 | 329.58M |
| May 21, 2024 | 334.17M |
| May 20, 2024 | 340.51M |
| May 17, 2024 | 333.46M |
| May 16, 2024 | 351.09M |
| May 15, 2024 | 295.39M |
| May 14, 2024 | 293.98M |
| May 13, 2024 | 290.46M |
| May 10, 2024 | 288.34M |
| May 09, 2024 | 315.84M |
| May 08, 2024 | 313.02M |
| May 07, 2024 | 324.65M |
| May 06, 2024 | 332.05M |
| May 03, 2024 | 341.92M |
| May 02, 2024 | 346.15M |
| May 01, 2024 | 329.94M |
| April 30, 2024 | 263.67M |
| April 29, 2024 | 270.36M |
| April 26, 2024 | 277.06M |
| Date | Value |
|---|---|
| April 25, 2024 | 286.23M |
| April 24, 2024 | 298.92M |
| April 23, 2024 | 306.67M |
| April 22, 2024 | 303.15M |
| April 19, 2024 | 315.13M |
| April 18, 2024 | 306.67M |
| April 17, 2024 | 308.79M |
| April 16, 2024 | 335.58M |
| April 15, 2024 | 329.23M |
| April 12, 2024 | 324.30M |
| April 11, 2024 | 324.30M |
| April 10, 2024 | 334.87M |
| April 09, 2024 | 355.32M |
| April 08, 2024 | 332.76M |
| April 05, 2024 | 341.22M |
| April 04, 2024 | 345.45M |
| April 03, 2024 | 365.19M |
| April 02, 2024 | 369.39M |
| April 01, 2024 | 394.06M |
| March 28, 2024 | 387.34M |
| March 27, 2024 | 408.82M |
| March 26, 2024 | 412.70M |
| March 25, 2024 | 460.59M |
| March 22, 2024 | 471.86M |
| March 21, 2024 | 517.63M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
112.55M
Minimum
Jan 18 2024
2.658B
Maximum
Mar 03 2023
1.180B
Average
955.06M
Median
Market Cap Benchmarks
| Anavex Life Sciences Corp | 344.91M |
| Checkpoint Therapeutics Inc | 70.02M |
| CERo Therapeutics Holdings Inc | 14.01M |
| Lexicon Pharmaceuticals Inc | 614.54M |
| Altimmune Inc | 532.48M |
Market Cap Related Metrics
| Price to Book Value | 1.102 |
| Price | 4.80 |
| Earnings Yield | -67.50% |